These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18052320)

  • 1. N,N'-dihydroxyamidines: a new prodrug principle to improve the oral bioavailability of amidines.
    Reeh C; Wundt J; Clement B
    J Med Chem; 2007 Dec; 50(26):6730-4. PubMed ID: 18052320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailability.
    Riggs JR; Kolesnikov A; Hendrix J; Young WB; Shrader WD; Vijaykumar D; Stephens R; Liu L; Pan L; Mordenti J; Green MJ; Sukbuntherng J
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2224-8. PubMed ID: 16458507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of L-valine-amidoximeesters as double prodrugs of amidines.
    Kotthaus J; Hungeling H; Reeh C; Kotthaus J; Schade D; Wein S; Wolffram S; Clement B
    Bioorg Med Chem; 2011 Mar; 19(6):1907-14. PubMed ID: 21345682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
    Clement B; Mau S; Deters S; Havemeyer A
    Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of highly potent amidine containing inhibitors of serine proteases and their N-hydroxylated prodrugs (amidoximes).
    Kotthaus J; Steinmetzer T; van de Locht A; Clement B
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):115-22. PubMed ID: 20583861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
    Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
    J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally active factor Xa inhibitors: investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy.
    Uchida M; Okazaki K; Mukaiyama H; Isawa H; Kobayashi H; Shiohara H; Muranaka H; Kai Y; Kikuchi N; Takeuchi H; Yokoyama K; Tsuji E; Ozawa T; Hoyano Y; Koizumi T; Misawa K; Hara K; Nakano S; Murakami Y; Okuno H
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4682-7. PubMed ID: 18667303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-substituted bis-C-alkyloxadiazolones as dual effectors: efficient intermediates to amidoximes or amidines and prodrug candidates of potent antimalarials.
    Degardin M; Wein S; Durand T; Escale R; Vial H; Vo-Hoang Y
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5233-6. PubMed ID: 19643611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
    Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
    Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug.
    Clement B; Lopian K
    Drug Metab Dispos; 2003 May; 31(5):645-51. PubMed ID: 12695354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally active factor Xa inhibitor: synthesis and biological activity of masked amidines as prodrugs of novel 1,4-diazepane derivatives.
    Koshio H; Hirayama F; Ishihara T; Kaizawa H; Shigenaga T; Taniuchi Y; Sato K; Moritani Y; Iwatsuki Y; Uemura T; Kaku S; Kawasaki T; Matsumoto Y; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2004 Oct; 12(20):5415-26. PubMed ID: 15388168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical and mARC-catalyzed enzymatic reduction of para-substituted benzamidoximes: consequences for the prodrug concept "amidoximes instead of amidines".
    Bauch E; Reichmann D; Mendel RR; Bittner F; Manke AM; Kurz P; Girreser U; Havemeyer A; Clement B
    ChemMedChem; 2015 Feb; 10(2):360-7. PubMed ID: 25512261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
    Gruenewald S; Wahl B; Bittner F; Hungeling H; Kanzow S; Kotthaus J; Schwering U; Mendel RR; Clement B
    J Med Chem; 2008 Dec; 51(24):8173-7. PubMed ID: 19053771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
    Xie Q; Wang X; Wang X; Jiang Z; Qiu Z
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent.
    Benzaria S; Pierra C; Bardiot D; Cretton-Scott E; Bridges EG; Zhou XJ; Standring D; Gosselin G
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1003-6. PubMed ID: 14565331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New prodrugs of the antiprotozoal drug pentamidine.
    Kotthaus J; Kotthaus J; Schade D; Schwering U; Hungeling H; Müller-Fielitz H; Raasch W; Clement B
    ChemMedChem; 2011 Dec; 6(12):2233-42. PubMed ID: 21984033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.
    Hecker SJ; Reddy KR; van Poelje PD; Sun Z; Huang W; Varkhedkar V; Reddy MV; Fujitaki JM; Olsen DB; Koeplinger KA; Boyer SH; Linemeyer DL; MacCoss M; Erion MD
    J Med Chem; 2007 Aug; 50(16):3891-6. PubMed ID: 17636948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of rat and human in vitro systems to assess the effectiveness and enzymology of deoxyguanine analogs as prodrugs of an antiviral agent.
    Harrell AW; Wheeler SM; East P; Clarke SE; Chenery RJ
    Drug Metab Dispos; 1994; 22(2):189-93. PubMed ID: 8013273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
    J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bioavailability of tricin-amino acid derivatives via a prodrug approach.
    Ninomiya M; Tanaka K; Tsuchida Y; Muto Y; Koketsu M; Watanabe K
    J Med Chem; 2011 Mar; 54(5):1529-36. PubMed ID: 21319803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.